Business Daily Media

Business Marketing

.

Eisai: All-case Surveillance Condition for Approval of Actonel 17.5 mg tablets for Treatment of Paget's Disease of Bone Cleared in Japan

  • Written by ACN Newswire - Press Releases

image

TOKYO, Mar 19, 2020 - (JCN Newswire) - EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has given notification of the results of reexamination to the effect that the "all-case surveillance" specified drug use-results survey condition required for the approval of

Read more //?#

Popular

State Lockdown: HungryPanda Empowers Struggling Chinese Restaurants

There’s no doubt that the ever-changing COVID-19 pandemic has been especially difficult for hospitality businesses, with lockdowns forced and businesses pivoting to takeaway. However, the impact has been extremely challenging ...

The Best Digital Marketing Strategies for E-Commerce Stores

E-Commerce is having a moment. It's projected to be a $4.9 trillion industry by the end of 2021. Those predictions were made before Coronavirus came and turned everything on its head, so if anything, they’re a tad conservati...

Sifting through the hype to unmask AI imposters

This year will be the year we expose shallow AI solutions for what they really are – impostors sporting a fake name badge. Many SaaS offerings have marketed themselves as AI-driven, but in reality, lack true AI-driven capabili...